Clinical Trial Update: Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

View source ↗

Summary

A clinical trial update evaluating a PD-1 monoclonal antibody in combination with rhG-CSF, IL-2, and CapeOX for initially resectable synchronous colorectal live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Drugs mentioned

• Capecitabine (capecitabine)
• Interleukin-2 (interleukin-2)
• OXALIPLATIN (Oxaliplatin)
• PD-1 monoclonal antibody
• recombinant human granulocyte colony-stimulating factor (filgrastim)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Colorectal Cancer | Status: NOT_YET_RECRUITING